Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Typhocon Immunogenicity and Safety in Healthy Bangladeshi Population
NCT05475379Phase 2Completed
- Sponsor
- icddr,b
- Start
- Jul 2022
- Primary completion
- Jun 2023
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of Typhocon in typhoid fever, sponsored by icddr,b. Started Jul 2022; status: completed.
02
Drugs
Typhocon
03
Conditions
typhoid fever
Beyond the preview
Go deeper on NCT05475379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05475379.